UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology ▲ |
---|---|---|---|---|---|
A0A7L1Y7B0 | GFRA1 protein (Fragment) |
|
2 | 0 |
|
A0A7L1Z3Z4 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1Z0B9 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1YE90 | AMD monooxygenase (Fragment) |
|
1 | 0 |
|
A0A7L1YJR6 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7L1Y9R2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1Z1Y5 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7L1YPN3 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1YJW0 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1YV55 | KCNKH protein (Fragment) |
|
1 | 0 |
|
A0A7L1YV12 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1Z1Y9 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1Y4H6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1Z4Y0 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L1Z0G7 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7L1YRE2 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1YJH9 | Angiotensin-converting enzyme (Fragment) |
|
1 | 0 |
|
A0A7L1Z8R8 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1Y4Z0 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1Y1R2 | P2RX6 protein (Fragment) |
|
1 | 0 |
|
A0A7L1Z0B2 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
2 | 0 |
|
A0A7L1Y944 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1YKU6 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7L1YBV1 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1Y209 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024